A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction

Conditions: Chronic Heart Failure With Reduced Ejection Fraction Interventions: Drug: Vericiguat (BAY1021189) 5 mg Sponsors: Bayer; Merck Sharp& Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials